Study on Bioequivalence of 2 Kinds of Ribavirin Preparations in Human Volunteers
Dawei Xiao
Abstract
Dawei Xiao
Abstract
OBJECTIVE:To study bioequivalence of 2 kinds of ribavirin preparations.METHODS:In randomized crossover design,the plasma concentration of ribavirin in 20 healthy volunteers was determined by LC-MS after oral administration of Ribavirin effervescent tablet 150 mg(test preparation) and Ribavirin granules(reference preparation),and the major pharmacokinetic parameters were calculated.RESULTS:The main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:t1/2(44.00±8.75)h vs.(44.89±10.44)h;tmax(1.0±0.7) h vs.(0.8±0.2) h;cmax(424.12±133.03)ng·mL-1 vs.(406.09±108.22)ng·mL-1;AUC0~108 h(4 997.59±1 322.31)ng·h·mL-1 vs.(4 921.16±1 030.61)ng·h·mL-1.The relative bioavailability of test tablet was(105.4±37.4)% by AUC0~108 h.The statistical result showed that there was no significant difference between 2 preparations in the t1/2,cmax,tmax,AUC0~108 h.CONCLUSION:The method is specific,sensitive and accurate.The two preparations are bioequivalent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To study bioequivalence of 2 kinds of ribavirin preparations.METHODS:In randomized crossover design,the plasma concentration of ribavirin in 20 healthy volunteers was determined by LC-MS after oral administration of Ribavirin effervescent tablet 150 mg(test preparation) and Ribavirin granules(reference preparation),and the major pharmacokinetic parameters were calculated.RESULTS:The main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:t1/2(44.00±8.75)h vs.(44.89±10.44)h;tmax(1.0±0.7) h vs.(0.8±0.2) h;cmax(424.12±133.03)ng·mL-1 vs.(406.09±108.22)ng·mL-1;AUC0~108 h(4 997.59±1 322.31)ng·h·mL-1 vs.(4 921.16±1 030.61)ng·h·mL-1.The relative bioavailability of test tablet was(105.4±37.4)% by AUC0~108 h.The statistical result showed that there was no significant difference between 2 preparations in the t1/2,cmax,tmax,AUC0~108 h.CONCLUSION:The method is specific,sensitive and accurate.The two preparations are bioequivalent.
Key concepts: Bioequivalence, Cmax, Bioavailability, Ribavirin, Pharmacokinetics, Pharmacology, Crossover study, Chromatography